|
RU2730998C2
|
|
Phorbol ester compositions and methods of using them for treating or reducing duration of cytopenia
|
|
TW201735915A
|
|
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
TW201444554A
|
|
Compositions and methods of use of phorbol esters
|
|
TW201442704A
|
|
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
TW201936181A
|
|
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
US2014017196A1
|
|
Compositions and methods of use of phorbol esters
|
|
US2014011873A1
|
|
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
US2014018329A1
|
|
Compositions and methods of use of phorbol esters in the treatment of neoplasms
|
|
US2015071908A1
|
|
Compositions and methods of use of phorbal esters for the treatment of stroke
|
|
US2015071874A1
|
|
Compositions And Methods Of Use Of Phorbol Esters
|
|
US2015072960A1
|
|
Compositions and methods of use of phorbol esters in the treatment of neoplasms
|
|
SG10201902370QA
|
|
Compositions and methods of use of phorbol esters
|
|
US2014106005A1
|
|
Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms
|
|
US2014140979A1
|
|
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
AU2012200980A1
|
|
Compositions and methods of use of phorbol esters
|
|
NZ735131A
|
|
Compositions and methods of use of phorbol esters
|
|
TW200522938A
|
|
Pharmaceutical composition for elevating white blood cells
|
